On Monday, Shares of ICICI Bank Ltd. (NYSE:IBN), gained 1.07% to $10.39, as Financial stocks posted strong gains Monday with the NYSE Financial Sector Index climbing nearly 1.2% and the S&P Financial 100 Index adding almost 0.8%.
ICICI Bank Limited, together with its auxiliaries, provides banking and financial services in India and internationally. The company operates through Retail Banking, Wholesale Banking, Treasury, Other Banking, Life Insurance, General Insurance, and Others segments.
Shares of Corning Inc. (NYSE:GLW), inclined 0.57% to $21.06, during its last trading session.
Corning Incorporated, and Tianma Micro-Electronics Group declared Tianma`s selection of Corning Lotus(TM) NXT Glass for its two new low-temperature polysilicon (LTPS) display panel models.
Tianma successfully incorporated Lotus NXT Glass into its 5.46-inch and 4.97-inch full high-definition products. Tianma creates LTPS panels for use in high-resolution smartphones and tablets that feature upward of 500 pixels per inch (ppi).
Lotus NXT Glass provides industry-leading levels of minimal total pitch variation. This allows panel makers to use tighter design rules, assisting them improve yields and develop higher-resolution devices with lower power consumption.
Corning unveiled Lotus NXT Glass June 1 at Display Week in San Jose, Calif., an industry tradeshow hosted by the Society for Information Display.
Corning Incorporated manufactures and sells specialty glasses, ceramics, and related materials worldwide. The company operates through five segments: Display Technologies, Optical Communications, Environmental Technologies, Specialty Materials, and Life Sciences.
Finally, Johnson & Johnson (NYSE:JNJ), ended its last trade with 0.23% gain, and closed at $100.09.
Johnson & Johnson, named Dr. Bert Vogelstein of Johns Hopkins University, Johns Hopkins Kimmel Cancer Center and the Howard Hughes Medical Institute, the winner of the 2015 Dr. Paul Janssen Award for Biomedical Research for his breakthroughs in oncology research, which have spanned more than two decades and have formed the basis of modern cancer research.
Dr. Vogelstein was honored last night during a reception at the 2015 BIO International Convention in Philadelphia.
“Dr. Vogelstein’s work forms the paradigm for understanding how nearly all forms of human tumors arise and progress,” said Paul Stoffels, M.D., Chief Scientific Officer and Worldwide Chairman, Pharmaceuticals, Johnson & Johnson. “His discoveries triggered a new wave of innovation in the field, resulting in transformational solutions for patients. It is a great honor to recognize the work of researchers like Dr. Vogelstein, who embody the same tenacity and commitment to improving human health as Dr. Paul.”
Johnson & Johnson, together with its auxiliaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
